Plasma exchange therapy in autoimmune hemolytic anemia (AIHA) was used in four patients (two with warm hemolytic anemia and two with cold hemolytic anemia). The size of each plasma exchange approximated I plasma volume; three consecutive daily exchanges removed 80-90% of the immunoglobulins-immunogl
Synchronization of plasma exchange and cyclophosphamide in severe and refractory autoimmune hemolytic anemia
✍ Scribed by Victor A. Silva; Richard H. Seder; Lewis R. Weintraub
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 361 KB
- Volume
- 9
- Category
- Article
- ISSN
- 0733-2459
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Two cases of severe autoimmune hemolytic anemia (AIHA) that failed multiple treatment modalities obtained complete and long‐lasting remissions with a combination of three one volume plasma exchange (PE) on succeeding days followed 6 hours later on the 3rd day by cyclophosphamide (cyc) 750 mg/m^2^ IV, and cyc/prednisone (pred) qd tapering to either no therapy or minimal therapy over a 6 month period. Both cases remain without evidence of AIHA after 43 and 19 months follow‐up. Possible non‐exclusive mechanisms that explain this favorable outcome are enhanced cytotoxic effect of cyc on proliferating lymphocytes participating in the antibody rebound phenomena, suppression of B lymphocytes with daily cyc/pred, and/or formation of anti‐idiotype antibodies.
We present two cases of severe and refractory AIHA, one warm and the other cold, that obtained complete and long‐lasting responses to a synchronized therapy of three daily one volume PE followed 6 hours later by cyc 750 mg/m^2^ IV and low doses of daily cyc and pred. In both cases the auto‐antibodies virtually disappeared. In one case, red cell allo‐antibodies disappeared as well.
📜 SIMILAR VOLUMES
We report the smallest infant (7.5 kg) to receive intensive plasma exchange (52 PEs) therapy as treatment of autoimmune hemolytic anemia (AIHA). PE temporarily reduces circulating autoantibody levels and can be an effective adjunctive therapy with corticosteroids and cytotoxic drugs or other immuno-
Severe autoimmune hemolytic anemia (AIHA) can cause life-threatening hemolysis requiring red blood cell transfusions (RBT). The efficiency of RBT could be improved with the use of plasma exchanges (PEx) before RBT. The objective of this study was to assess the effectiveness of PEx in severe AIHA of